Pharma & Healthcare
Global Incretin-Based Drugs Market Research Report 2025
- Sep 09, 25
- ID: 496722
- Pages: 78
- Figures: 82
- Views: 4
Report Scope
This report aims to provide a comprehensive presentation of the global market for Incretin-Based Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Incretin-Based Drugs.
The Incretin-Based Drugs market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Incretin-Based Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Incretin-Based Drugs manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
GlaxoSmithKline
Johnson & Johnson
Merck & Co
AstraZeneca
Novartis
Eli Lilly and Company
Boehringer Ingelheim
Takeda Pharmaceutical Company
Sanofi
Segment by Type
Glucagon-like peptide-1 receptor (GLP-1) agonists
Dipeptidyl Peptidase-4 (DPP-4) inhibitors
Segment by Application
Oral Drugs
Injectable Drugs
Consumption by Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Incretin-Based Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Incretin-Based Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
This report aims to provide a comprehensive presentation of the global market for Incretin-Based Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Incretin-Based Drugs.
The Incretin-Based Drugs market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Incretin-Based Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Incretin-Based Drugs manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
GlaxoSmithKline
Johnson & Johnson
Merck & Co
AstraZeneca
Novartis
Eli Lilly and Company
Boehringer Ingelheim
Takeda Pharmaceutical Company
Sanofi
Segment by Type
Glucagon-like peptide-1 receptor (GLP-1) agonists
Dipeptidyl Peptidase-4 (DPP-4) inhibitors
Segment by Application
Oral Drugs
Injectable Drugs
Consumption by Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Incretin-Based Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Incretin-Based Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
1 Incretin-Based Drugs Market Overview
1.1 Product Definition
1.2 Incretin-Based Drugs by Type
1.2.1 Global Incretin-Based Drugs Market Value Comparison by Type (2024 VS 2031)
1.2.2 Glucagon-like peptide-1 receptor (GLP-1) agonists
1.2.3 Dipeptidyl Peptidase-4 (DPP-4) inhibitors
1.3 Incretin-Based Drugs by Application
1.3.1 Global Incretin-Based Drugs Market Value by Application (2024 VS 2031)
1.3.2 Oral Drugs
1.3.3 Injectable Drugs
1.4 Global Incretin-Based Drugs Market Size Estimates and Forecasts
1.4.1 Global Incretin-Based Drugs Revenue 2020-2031
1.4.2 Global Incretin-Based Drugs Sales 2020-2031
1.4.3 Global Incretin-Based Drugs Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Incretin-Based Drugs Market Competition by Manufacturers
2.1 Global Incretin-Based Drugs Sales Market Share by Manufacturers (2020-2025)
2.2 Global Incretin-Based Drugs Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Incretin-Based Drugs Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Incretin-Based Drugs, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Incretin-Based Drugs, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Incretin-Based Drugs, Product Type & Application
2.7 Global Key Manufacturers of Incretin-Based Drugs, Date of Enter into This Industry
2.8 Global Incretin-Based Drugs Market Competitive Situation and Trends
2.8.1 Global Incretin-Based Drugs Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Incretin-Based Drugs Players Market Share by Revenue
2.8.3 Global Incretin-Based Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Incretin-Based Drugs Market Scenario by Region
3.1 Global Incretin-Based Drugs Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Incretin-Based Drugs Sales by Region: 2020-2031
3.2.1 Global Incretin-Based Drugs Sales by Region: 2020-2025
3.2.2 Global Incretin-Based Drugs Sales by Region: 2026-2031
3.3 Global Incretin-Based Drugs Revenue by Region: 2020-2031
3.3.1 Global Incretin-Based Drugs Revenue by Region: 2020-2025
3.3.2 Global Incretin-Based Drugs Revenue by Region: 2026-2031
3.4 North America Incretin-Based Drugs Market Facts & Figures by Country
3.4.1 North America Incretin-Based Drugs Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Incretin-Based Drugs Sales by Country (2020-2031)
3.4.3 North America Incretin-Based Drugs Revenue by Country (2020-2031)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Incretin-Based Drugs Market Facts & Figures by Country
3.5.1 Europe Incretin-Based Drugs Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Incretin-Based Drugs Sales by Country (2020-2031)
3.5.3 Europe Incretin-Based Drugs Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Incretin-Based Drugs Market Facts & Figures by Region
3.6.1 Asia Pacific Incretin-Based Drugs Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Incretin-Based Drugs Sales by Region (2020-2031)
3.6.3 Asia Pacific Incretin-Based Drugs Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Incretin-Based Drugs Market Facts & Figures by Country
3.7.1 Latin America Incretin-Based Drugs Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Incretin-Based Drugs Sales by Country (2020-2031)
3.7.3 Latin America Incretin-Based Drugs Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Incretin-Based Drugs Market Facts & Figures by Country
3.8.1 Middle East and Africa Incretin-Based Drugs Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Incretin-Based Drugs Sales by Country (2020-2031)
3.8.3 Middle East and Africa Incretin-Based Drugs Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Incretin-Based Drugs Sales by Type (2020-2031)
4.1.1 Global Incretin-Based Drugs Sales by Type (2020-2025)
4.1.2 Global Incretin-Based Drugs Sales by Type (2026-2031)
4.1.3 Global Incretin-Based Drugs Sales Market Share by Type (2020-2031)
4.2 Global Incretin-Based Drugs Revenue by Type (2020-2031)
4.2.1 Global Incretin-Based Drugs Revenue by Type (2020-2025)
4.2.2 Global Incretin-Based Drugs Revenue by Type (2026-2031)
4.2.3 Global Incretin-Based Drugs Revenue Market Share by Type (2020-2031)
4.3 Global Incretin-Based Drugs Price by Type (2020-2031)
5 Segment by Application
5.1 Global Incretin-Based Drugs Sales by Application (2020-2031)
5.1.1 Global Incretin-Based Drugs Sales by Application (2020-2025)
5.1.2 Global Incretin-Based Drugs Sales by Application (2026-2031)
5.1.3 Global Incretin-Based Drugs Sales Market Share by Application (2020-2031)
5.2 Global Incretin-Based Drugs Revenue by Application (2020-2031)
5.2.1 Global Incretin-Based Drugs Revenue by Application (2020-2025)
5.2.2 Global Incretin-Based Drugs Revenue by Application (2026-2031)
5.2.3 Global Incretin-Based Drugs Revenue Market Share by Application (2020-2031)
5.3 Global Incretin-Based Drugs Price by Application (2020-2031)
6 Key Companies Profiled
6.1 GlaxoSmithKline
6.1.1 GlaxoSmithKline Company Information
6.1.2 GlaxoSmithKline Description and Business Overview
6.1.3 GlaxoSmithKline Incretin-Based Drugs Sales, Revenue and Gross Margin (2020-2025)
6.1.4 GlaxoSmithKline Incretin-Based Drugs Product Portfolio
6.1.5 GlaxoSmithKline Recent Developments/Updates
6.2 Johnson & Johnson
6.2.1 Johnson & Johnson Company Information
6.2.2 Johnson & Johnson Description and Business Overview
6.2.3 Johnson & Johnson Incretin-Based Drugs Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Johnson & Johnson Incretin-Based Drugs Product Portfolio
6.2.5 Johnson & Johnson Recent Developments/Updates
6.3 Merck & Co
6.3.1 Merck & Co Company Information
6.3.2 Merck & Co Description and Business Overview
6.3.3 Merck & Co Incretin-Based Drugs Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Merck & Co Incretin-Based Drugs Product Portfolio
6.3.5 Merck & Co Recent Developments/Updates
6.4 AstraZeneca
6.4.1 AstraZeneca Company Information
6.4.2 AstraZeneca Description and Business Overview
6.4.3 AstraZeneca Incretin-Based Drugs Sales, Revenue and Gross Margin (2020-2025)
6.4.4 AstraZeneca Incretin-Based Drugs Product Portfolio
6.4.5 AstraZeneca Recent Developments/Updates
6.5 Novartis
6.5.1 Novartis Company Information
6.5.2 Novartis Description and Business Overview
6.5.3 Novartis Incretin-Based Drugs Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Novartis Incretin-Based Drugs Product Portfolio
6.5.5 Novartis Recent Developments/Updates
6.6 Eli Lilly and Company
6.6.1 Eli Lilly and Company Company Information
6.6.2 Eli Lilly and Company Description and Business Overview
6.6.3 Eli Lilly and Company Incretin-Based Drugs Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Eli Lilly and Company Incretin-Based Drugs Product Portfolio
6.6.5 Eli Lilly and Company Recent Developments/Updates
6.7 Boehringer Ingelheim
6.7.1 Boehringer Ingelheim Company Information
6.7.2 Boehringer Ingelheim Description and Business Overview
6.7.3 Boehringer Ingelheim Incretin-Based Drugs Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Boehringer Ingelheim Incretin-Based Drugs Product Portfolio
6.7.5 Boehringer Ingelheim Recent Developments/Updates
6.8 Takeda Pharmaceutical Company
6.8.1 Takeda Pharmaceutical Company Company Information
6.8.2 Takeda Pharmaceutical Company Description and Business Overview
6.8.3 Takeda Pharmaceutical Company Incretin-Based Drugs Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Takeda Pharmaceutical Company Incretin-Based Drugs Product Portfolio
6.8.5 Takeda Pharmaceutical Company Recent Developments/Updates
6.9 Sanofi
6.9.1 Sanofi Company Information
6.9.2 Sanofi Description and Business Overview
6.9.3 Sanofi Incretin-Based Drugs Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Sanofi Incretin-Based Drugs Product Portfolio
6.9.5 Sanofi Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Incretin-Based Drugs Industry Chain Analysis
7.2 Incretin-Based Drugs Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Incretin-Based Drugs Production Mode & Process Analysis
7.4 Incretin-Based Drugs Sales and Marketing
7.4.1 Incretin-Based Drugs Sales Channels
7.4.2 Incretin-Based Drugs Distributors
7.5 Incretin-Based Drugs Customer Analysis
8 Incretin-Based Drugs Market Dynamics
8.1 Incretin-Based Drugs Industry Trends
8.2 Incretin-Based Drugs Market Drivers
8.3 Incretin-Based Drugs Market Challenges
8.4 Incretin-Based Drugs Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
1.1 Product Definition
1.2 Incretin-Based Drugs by Type
1.2.1 Global Incretin-Based Drugs Market Value Comparison by Type (2024 VS 2031)
1.2.2 Glucagon-like peptide-1 receptor (GLP-1) agonists
1.2.3 Dipeptidyl Peptidase-4 (DPP-4) inhibitors
1.3 Incretin-Based Drugs by Application
1.3.1 Global Incretin-Based Drugs Market Value by Application (2024 VS 2031)
1.3.2 Oral Drugs
1.3.3 Injectable Drugs
1.4 Global Incretin-Based Drugs Market Size Estimates and Forecasts
1.4.1 Global Incretin-Based Drugs Revenue 2020-2031
1.4.2 Global Incretin-Based Drugs Sales 2020-2031
1.4.3 Global Incretin-Based Drugs Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Incretin-Based Drugs Market Competition by Manufacturers
2.1 Global Incretin-Based Drugs Sales Market Share by Manufacturers (2020-2025)
2.2 Global Incretin-Based Drugs Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Incretin-Based Drugs Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Incretin-Based Drugs, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Incretin-Based Drugs, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Incretin-Based Drugs, Product Type & Application
2.7 Global Key Manufacturers of Incretin-Based Drugs, Date of Enter into This Industry
2.8 Global Incretin-Based Drugs Market Competitive Situation and Trends
2.8.1 Global Incretin-Based Drugs Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Incretin-Based Drugs Players Market Share by Revenue
2.8.3 Global Incretin-Based Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Incretin-Based Drugs Market Scenario by Region
3.1 Global Incretin-Based Drugs Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Incretin-Based Drugs Sales by Region: 2020-2031
3.2.1 Global Incretin-Based Drugs Sales by Region: 2020-2025
3.2.2 Global Incretin-Based Drugs Sales by Region: 2026-2031
3.3 Global Incretin-Based Drugs Revenue by Region: 2020-2031
3.3.1 Global Incretin-Based Drugs Revenue by Region: 2020-2025
3.3.2 Global Incretin-Based Drugs Revenue by Region: 2026-2031
3.4 North America Incretin-Based Drugs Market Facts & Figures by Country
3.4.1 North America Incretin-Based Drugs Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Incretin-Based Drugs Sales by Country (2020-2031)
3.4.3 North America Incretin-Based Drugs Revenue by Country (2020-2031)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Incretin-Based Drugs Market Facts & Figures by Country
3.5.1 Europe Incretin-Based Drugs Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Incretin-Based Drugs Sales by Country (2020-2031)
3.5.3 Europe Incretin-Based Drugs Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Incretin-Based Drugs Market Facts & Figures by Region
3.6.1 Asia Pacific Incretin-Based Drugs Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Incretin-Based Drugs Sales by Region (2020-2031)
3.6.3 Asia Pacific Incretin-Based Drugs Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Incretin-Based Drugs Market Facts & Figures by Country
3.7.1 Latin America Incretin-Based Drugs Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Incretin-Based Drugs Sales by Country (2020-2031)
3.7.3 Latin America Incretin-Based Drugs Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Incretin-Based Drugs Market Facts & Figures by Country
3.8.1 Middle East and Africa Incretin-Based Drugs Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Incretin-Based Drugs Sales by Country (2020-2031)
3.8.3 Middle East and Africa Incretin-Based Drugs Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Incretin-Based Drugs Sales by Type (2020-2031)
4.1.1 Global Incretin-Based Drugs Sales by Type (2020-2025)
4.1.2 Global Incretin-Based Drugs Sales by Type (2026-2031)
4.1.3 Global Incretin-Based Drugs Sales Market Share by Type (2020-2031)
4.2 Global Incretin-Based Drugs Revenue by Type (2020-2031)
4.2.1 Global Incretin-Based Drugs Revenue by Type (2020-2025)
4.2.2 Global Incretin-Based Drugs Revenue by Type (2026-2031)
4.2.3 Global Incretin-Based Drugs Revenue Market Share by Type (2020-2031)
4.3 Global Incretin-Based Drugs Price by Type (2020-2031)
5 Segment by Application
5.1 Global Incretin-Based Drugs Sales by Application (2020-2031)
5.1.1 Global Incretin-Based Drugs Sales by Application (2020-2025)
5.1.2 Global Incretin-Based Drugs Sales by Application (2026-2031)
5.1.3 Global Incretin-Based Drugs Sales Market Share by Application (2020-2031)
5.2 Global Incretin-Based Drugs Revenue by Application (2020-2031)
5.2.1 Global Incretin-Based Drugs Revenue by Application (2020-2025)
5.2.2 Global Incretin-Based Drugs Revenue by Application (2026-2031)
5.2.3 Global Incretin-Based Drugs Revenue Market Share by Application (2020-2031)
5.3 Global Incretin-Based Drugs Price by Application (2020-2031)
6 Key Companies Profiled
6.1 GlaxoSmithKline
6.1.1 GlaxoSmithKline Company Information
6.1.2 GlaxoSmithKline Description and Business Overview
6.1.3 GlaxoSmithKline Incretin-Based Drugs Sales, Revenue and Gross Margin (2020-2025)
6.1.4 GlaxoSmithKline Incretin-Based Drugs Product Portfolio
6.1.5 GlaxoSmithKline Recent Developments/Updates
6.2 Johnson & Johnson
6.2.1 Johnson & Johnson Company Information
6.2.2 Johnson & Johnson Description and Business Overview
6.2.3 Johnson & Johnson Incretin-Based Drugs Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Johnson & Johnson Incretin-Based Drugs Product Portfolio
6.2.5 Johnson & Johnson Recent Developments/Updates
6.3 Merck & Co
6.3.1 Merck & Co Company Information
6.3.2 Merck & Co Description and Business Overview
6.3.3 Merck & Co Incretin-Based Drugs Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Merck & Co Incretin-Based Drugs Product Portfolio
6.3.5 Merck & Co Recent Developments/Updates
6.4 AstraZeneca
6.4.1 AstraZeneca Company Information
6.4.2 AstraZeneca Description and Business Overview
6.4.3 AstraZeneca Incretin-Based Drugs Sales, Revenue and Gross Margin (2020-2025)
6.4.4 AstraZeneca Incretin-Based Drugs Product Portfolio
6.4.5 AstraZeneca Recent Developments/Updates
6.5 Novartis
6.5.1 Novartis Company Information
6.5.2 Novartis Description and Business Overview
6.5.3 Novartis Incretin-Based Drugs Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Novartis Incretin-Based Drugs Product Portfolio
6.5.5 Novartis Recent Developments/Updates
6.6 Eli Lilly and Company
6.6.1 Eli Lilly and Company Company Information
6.6.2 Eli Lilly and Company Description and Business Overview
6.6.3 Eli Lilly and Company Incretin-Based Drugs Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Eli Lilly and Company Incretin-Based Drugs Product Portfolio
6.6.5 Eli Lilly and Company Recent Developments/Updates
6.7 Boehringer Ingelheim
6.7.1 Boehringer Ingelheim Company Information
6.7.2 Boehringer Ingelheim Description and Business Overview
6.7.3 Boehringer Ingelheim Incretin-Based Drugs Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Boehringer Ingelheim Incretin-Based Drugs Product Portfolio
6.7.5 Boehringer Ingelheim Recent Developments/Updates
6.8 Takeda Pharmaceutical Company
6.8.1 Takeda Pharmaceutical Company Company Information
6.8.2 Takeda Pharmaceutical Company Description and Business Overview
6.8.3 Takeda Pharmaceutical Company Incretin-Based Drugs Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Takeda Pharmaceutical Company Incretin-Based Drugs Product Portfolio
6.8.5 Takeda Pharmaceutical Company Recent Developments/Updates
6.9 Sanofi
6.9.1 Sanofi Company Information
6.9.2 Sanofi Description and Business Overview
6.9.3 Sanofi Incretin-Based Drugs Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Sanofi Incretin-Based Drugs Product Portfolio
6.9.5 Sanofi Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Incretin-Based Drugs Industry Chain Analysis
7.2 Incretin-Based Drugs Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Incretin-Based Drugs Production Mode & Process Analysis
7.4 Incretin-Based Drugs Sales and Marketing
7.4.1 Incretin-Based Drugs Sales Channels
7.4.2 Incretin-Based Drugs Distributors
7.5 Incretin-Based Drugs Customer Analysis
8 Incretin-Based Drugs Market Dynamics
8.1 Incretin-Based Drugs Industry Trends
8.2 Incretin-Based Drugs Market Drivers
8.3 Incretin-Based Drugs Market Challenges
8.4 Incretin-Based Drugs Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
Table 1. Global Incretin-Based Drugs Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global Incretin-Based Drugs Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global Incretin-Based Drugs Market Competitive Situation by Manufacturers in 2024
Table 4. Global Incretin-Based Drugs Sales (K Units) of Key Manufacturers (2020-2025)
Table 5. Global Incretin-Based Drugs Sales Market Share by Manufacturers (2020-2025)
Table 6. Global Incretin-Based Drugs Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global Incretin-Based Drugs Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market Incretin-Based Drugs Average Price (US$/Unit) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of Incretin-Based Drugs, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Incretin-Based Drugs, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Incretin-Based Drugs, Product Type & Application
Table 12. Global Key Manufacturers of Incretin-Based Drugs, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Incretin-Based Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Incretin-Based Drugs as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Incretin-Based Drugs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global Incretin-Based Drugs Sales by Region (2020-2025) & (K Units)
Table 18. Global Incretin-Based Drugs Sales Market Share by Region (2020-2025)
Table 19. Global Incretin-Based Drugs Sales by Region (2026-2031) & (K Units)
Table 20. Global Incretin-Based Drugs Sales Market Share by Region (2026-2031)
Table 21. Global Incretin-Based Drugs Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global Incretin-Based Drugs Revenue Market Share by Region (2020-2025)
Table 23. Global Incretin-Based Drugs Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global Incretin-Based Drugs Revenue Market Share by Region (2026-2031)
Table 25. North America Incretin-Based Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America Incretin-Based Drugs Sales by Country (2020-2025) & (K Units)
Table 27. North America Incretin-Based Drugs Sales by Country (2026-2031) & (K Units)
Table 28. North America Incretin-Based Drugs Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America Incretin-Based Drugs Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe Incretin-Based Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe Incretin-Based Drugs Sales by Country (2020-2025) & (K Units)
Table 32. Europe Incretin-Based Drugs Sales by Country (2026-2031) & (K Units)
Table 33. Europe Incretin-Based Drugs Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe Incretin-Based Drugs Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific Incretin-Based Drugs Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific Incretin-Based Drugs Sales by Region (2020-2025) & (K Units)
Table 37. Asia Pacific Incretin-Based Drugs Sales by Region (2026-2031) & (K Units)
Table 38. Asia Pacific Incretin-Based Drugs Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific Incretin-Based Drugs Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America Incretin-Based Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America Incretin-Based Drugs Sales by Country (2020-2025) & (K Units)
Table 42. Latin America Incretin-Based Drugs Sales by Country (2026-2031) & (K Units)
Table 43. Latin America Incretin-Based Drugs Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America Incretin-Based Drugs Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa Incretin-Based Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa Incretin-Based Drugs Sales by Country (2020-2025) & (K Units)
Table 47. Middle East and Africa Incretin-Based Drugs Sales by Country (2026-2031) & (K Units)
Table 48. Middle East and Africa Incretin-Based Drugs Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa Incretin-Based Drugs Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global Incretin-Based Drugs Sales (K Units) by Type (2020-2025)
Table 51. Global Incretin-Based Drugs Sales (K Units) by Type (2026-2031)
Table 52. Global Incretin-Based Drugs Sales Market Share by Type (2020-2025)
Table 53. Global Incretin-Based Drugs Sales Market Share by Type (2026-2031)
Table 54. Global Incretin-Based Drugs Revenue (US$ Million) by Type (2020-2025)
Table 55. Global Incretin-Based Drugs Revenue (US$ Million) by Type (2026-2031)
Table 56. Global Incretin-Based Drugs Revenue Market Share by Type (2020-2025)
Table 57. Global Incretin-Based Drugs Revenue Market Share by Type (2026-2031)
Table 58. Global Incretin-Based Drugs Price (US$/Unit) by Type (2020-2025)
Table 59. Global Incretin-Based Drugs Price (US$/Unit) by Type (2026-2031)
Table 60. Global Incretin-Based Drugs Sales (K Units) by Application (2020-2025)
Table 61. Global Incretin-Based Drugs Sales (K Units) by Application (2026-2031)
Table 62. Global Incretin-Based Drugs Sales Market Share by Application (2020-2025)
Table 63. Global Incretin-Based Drugs Sales Market Share by Application (2026-2031)
Table 64. Global Incretin-Based Drugs Revenue (US$ Million) by Application (2020-2025)
Table 65. Global Incretin-Based Drugs Revenue (US$ Million) by Application (2026-2031)
Table 66. Global Incretin-Based Drugs Revenue Market Share by Application (2020-2025)
Table 67. Global Incretin-Based Drugs Revenue Market Share by Application (2026-2031)
Table 68. Global Incretin-Based Drugs Price (US$/Unit) by Application (2020-2025)
Table 69. Global Incretin-Based Drugs Price (US$/Unit) by Application (2026-2031)
Table 70. GlaxoSmithKline Company Information
Table 71. GlaxoSmithKline Description and Business Overview
Table 72. GlaxoSmithKline Incretin-Based Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 73. GlaxoSmithKline Incretin-Based Drugs Product
Table 74. GlaxoSmithKline Recent Developments/Updates
Table 75. Johnson & Johnson Company Information
Table 76. Johnson & Johnson Description and Business Overview
Table 77. Johnson & Johnson Incretin-Based Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 78. Johnson & Johnson Incretin-Based Drugs Product
Table 79. Johnson & Johnson Recent Developments/Updates
Table 80. Merck & Co Company Information
Table 81. Merck & Co Description and Business Overview
Table 82. Merck & Co Incretin-Based Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 83. Merck & Co Incretin-Based Drugs Product
Table 84. Merck & Co Recent Developments/Updates
Table 85. AstraZeneca Company Information
Table 86. AstraZeneca Description and Business Overview
Table 87. AstraZeneca Incretin-Based Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 88. AstraZeneca Incretin-Based Drugs Product
Table 89. AstraZeneca Recent Developments/Updates
Table 90. Novartis Company Information
Table 91. Novartis Description and Business Overview
Table 92. Novartis Incretin-Based Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 93. Novartis Incretin-Based Drugs Product
Table 94. Novartis Recent Developments/Updates
Table 95. Eli Lilly and Company Company Information
Table 96. Eli Lilly and Company Description and Business Overview
Table 97. Eli Lilly and Company Incretin-Based Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 98. Eli Lilly and Company Incretin-Based Drugs Product
Table 99. Eli Lilly and Company Recent Developments/Updates
Table 100. Boehringer Ingelheim Company Information
Table 101. Boehringer Ingelheim Description and Business Overview
Table 102. Boehringer Ingelheim Incretin-Based Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 103. Boehringer Ingelheim Incretin-Based Drugs Product
Table 104. Boehringer Ingelheim Recent Developments/Updates
Table 105. Takeda Pharmaceutical Company Company Information
Table 106. Takeda Pharmaceutical Company Description and Business Overview
Table 107. Takeda Pharmaceutical Company Incretin-Based Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 108. Takeda Pharmaceutical Company Incretin-Based Drugs Product
Table 109. Takeda Pharmaceutical Company Recent Developments/Updates
Table 110. Sanofi Company Information
Table 111. Sanofi Description and Business Overview
Table 112. Sanofi Incretin-Based Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 113. Sanofi Incretin-Based Drugs Product
Table 114. Sanofi Recent Developments/Updates
Table 115. Key Raw Materials Lists
Table 116. Raw Materials Key Suppliers Lists
Table 117. Incretin-Based Drugs Distributors List
Table 118. Incretin-Based Drugs Customers List
Table 119. Incretin-Based Drugs Market Trends
Table 120. Incretin-Based Drugs Market Drivers
Table 121. Incretin-Based Drugs Market Challenges
Table 122. Incretin-Based Drugs Market Restraints
Table 123. Research Programs/Design for This Report
Table 124. Key Data Information from Secondary Sources
Table 125. Key Data Information from Primary Sources
Table 126. Authors List of This Report
List of Figures
Figure 1. Product Picture of Incretin-Based Drugs
Figure 2. Global Incretin-Based Drugs Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Incretin-Based Drugs Market Share by Type: 2024 & 2031
Figure 4. Glucagon-like peptide-1 receptor (GLP-1) agonists Product Picture
Figure 5. Dipeptidyl Peptidase-4 (DPP-4) inhibitors Product Picture
Figure 6. Global Incretin-Based Drugs Market Value by Application (2020-2031) & (US$ Million)
Figure 7. Global Incretin-Based Drugs Market Share by Application: 2024 & 2031
Figure 8. Oral Drugs
Figure 9. Injectable Drugs
Figure 10. Global Incretin-Based Drugs Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 11. Global Incretin-Based Drugs Market Size (2020-2031) & (US$ Million)
Figure 12. Global Incretin-Based Drugs Sales (2020-2031) & (K Units)
Figure 13. Global Incretin-Based Drugs Average Price (US$/Unit) & (2020-2031)
Figure 14. Incretin-Based Drugs Report Years Considered
Figure 15. Incretin-Based Drugs Sales Share by Manufacturers in 2024
Figure 16. Global Incretin-Based Drugs Revenue Share by Manufacturers in 2024
Figure 17. Global 5 and 10 Largest Incretin-Based Drugs Players: Market Share by Revenue in Incretin-Based Drugs in 2024
Figure 18. Incretin-Based Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 19. Global Incretin-Based Drugs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 20. North America Incretin-Based Drugs Sales Market Share by Country (2020-2031)
Figure 21. North America Incretin-Based Drugs Revenue Market Share by Country (2020-2031)
Figure 22. U.S. Incretin-Based Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 23. Canada Incretin-Based Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 24. Europe Incretin-Based Drugs Sales Market Share by Country (2020-2031)
Figure 25. Europe Incretin-Based Drugs Revenue Market Share by Country (2020-2031)
Figure 26. Germany Incretin-Based Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 27. France Incretin-Based Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 28. U.K. Incretin-Based Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 29. Italy Incretin-Based Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 30. Russia Incretin-Based Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 31. Asia Pacific Incretin-Based Drugs Sales Market Share by Region (2020-2031)
Figure 32. Asia Pacific Incretin-Based Drugs Revenue Market Share by Region (2020-2031)
Figure 33. China Incretin-Based Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 34. Japan Incretin-Based Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 35. South Korea Incretin-Based Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 36. India Incretin-Based Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 37. Australia Incretin-Based Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 38. Taiwan Incretin-Based Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. Indonesia Incretin-Based Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. Thailand Incretin-Based Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. Malaysia Incretin-Based Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 42. Philippines Incretin-Based Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 43. Latin America Incretin-Based Drugs Sales Market Share by Country (2020-2031)
Figure 44. Latin America Incretin-Based Drugs Revenue Market Share by Country (2020-2031)
Figure 45. Mexico Incretin-Based Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 46. Brazil Incretin-Based Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 47. Argentina Incretin-Based Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 48. Middle East and Africa Incretin-Based Drugs Sales Market Share by Country (2020-2031)
Figure 49. Middle East and Africa Incretin-Based Drugs Revenue Market Share by Country (2020-2031)
Figure 50. Turkey Incretin-Based Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 51. Saudi Arabia Incretin-Based Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 52. UAE Incretin-Based Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 53. Global Sales Market Share of Incretin-Based Drugs by Type (2020-2031)
Figure 54. Global Revenue Market Share of Incretin-Based Drugs by Type (2020-2031)
Figure 55. Global Incretin-Based Drugs Price (US$/Unit) by Type (2020-2031)
Figure 56. Global Sales Market Share of Incretin-Based Drugs by Application (2020-2031)
Figure 57. Global Revenue Market Share of Incretin-Based Drugs by Application (2020-2031)
Figure 58. Global Incretin-Based Drugs Price (US$/Unit) by Application (2020-2031)
Figure 59. Incretin-Based Drugs Value Chain
Figure 60. Channels of Distribution (Direct Vs Distribution)
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed
Table 1. Global Incretin-Based Drugs Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global Incretin-Based Drugs Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global Incretin-Based Drugs Market Competitive Situation by Manufacturers in 2024
Table 4. Global Incretin-Based Drugs Sales (K Units) of Key Manufacturers (2020-2025)
Table 5. Global Incretin-Based Drugs Sales Market Share by Manufacturers (2020-2025)
Table 6. Global Incretin-Based Drugs Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global Incretin-Based Drugs Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market Incretin-Based Drugs Average Price (US$/Unit) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of Incretin-Based Drugs, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Incretin-Based Drugs, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Incretin-Based Drugs, Product Type & Application
Table 12. Global Key Manufacturers of Incretin-Based Drugs, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Incretin-Based Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Incretin-Based Drugs as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Incretin-Based Drugs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global Incretin-Based Drugs Sales by Region (2020-2025) & (K Units)
Table 18. Global Incretin-Based Drugs Sales Market Share by Region (2020-2025)
Table 19. Global Incretin-Based Drugs Sales by Region (2026-2031) & (K Units)
Table 20. Global Incretin-Based Drugs Sales Market Share by Region (2026-2031)
Table 21. Global Incretin-Based Drugs Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global Incretin-Based Drugs Revenue Market Share by Region (2020-2025)
Table 23. Global Incretin-Based Drugs Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global Incretin-Based Drugs Revenue Market Share by Region (2026-2031)
Table 25. North America Incretin-Based Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America Incretin-Based Drugs Sales by Country (2020-2025) & (K Units)
Table 27. North America Incretin-Based Drugs Sales by Country (2026-2031) & (K Units)
Table 28. North America Incretin-Based Drugs Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America Incretin-Based Drugs Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe Incretin-Based Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe Incretin-Based Drugs Sales by Country (2020-2025) & (K Units)
Table 32. Europe Incretin-Based Drugs Sales by Country (2026-2031) & (K Units)
Table 33. Europe Incretin-Based Drugs Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe Incretin-Based Drugs Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific Incretin-Based Drugs Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific Incretin-Based Drugs Sales by Region (2020-2025) & (K Units)
Table 37. Asia Pacific Incretin-Based Drugs Sales by Region (2026-2031) & (K Units)
Table 38. Asia Pacific Incretin-Based Drugs Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific Incretin-Based Drugs Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America Incretin-Based Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America Incretin-Based Drugs Sales by Country (2020-2025) & (K Units)
Table 42. Latin America Incretin-Based Drugs Sales by Country (2026-2031) & (K Units)
Table 43. Latin America Incretin-Based Drugs Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America Incretin-Based Drugs Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa Incretin-Based Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa Incretin-Based Drugs Sales by Country (2020-2025) & (K Units)
Table 47. Middle East and Africa Incretin-Based Drugs Sales by Country (2026-2031) & (K Units)
Table 48. Middle East and Africa Incretin-Based Drugs Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa Incretin-Based Drugs Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global Incretin-Based Drugs Sales (K Units) by Type (2020-2025)
Table 51. Global Incretin-Based Drugs Sales (K Units) by Type (2026-2031)
Table 52. Global Incretin-Based Drugs Sales Market Share by Type (2020-2025)
Table 53. Global Incretin-Based Drugs Sales Market Share by Type (2026-2031)
Table 54. Global Incretin-Based Drugs Revenue (US$ Million) by Type (2020-2025)
Table 55. Global Incretin-Based Drugs Revenue (US$ Million) by Type (2026-2031)
Table 56. Global Incretin-Based Drugs Revenue Market Share by Type (2020-2025)
Table 57. Global Incretin-Based Drugs Revenue Market Share by Type (2026-2031)
Table 58. Global Incretin-Based Drugs Price (US$/Unit) by Type (2020-2025)
Table 59. Global Incretin-Based Drugs Price (US$/Unit) by Type (2026-2031)
Table 60. Global Incretin-Based Drugs Sales (K Units) by Application (2020-2025)
Table 61. Global Incretin-Based Drugs Sales (K Units) by Application (2026-2031)
Table 62. Global Incretin-Based Drugs Sales Market Share by Application (2020-2025)
Table 63. Global Incretin-Based Drugs Sales Market Share by Application (2026-2031)
Table 64. Global Incretin-Based Drugs Revenue (US$ Million) by Application (2020-2025)
Table 65. Global Incretin-Based Drugs Revenue (US$ Million) by Application (2026-2031)
Table 66. Global Incretin-Based Drugs Revenue Market Share by Application (2020-2025)
Table 67. Global Incretin-Based Drugs Revenue Market Share by Application (2026-2031)
Table 68. Global Incretin-Based Drugs Price (US$/Unit) by Application (2020-2025)
Table 69. Global Incretin-Based Drugs Price (US$/Unit) by Application (2026-2031)
Table 70. GlaxoSmithKline Company Information
Table 71. GlaxoSmithKline Description and Business Overview
Table 72. GlaxoSmithKline Incretin-Based Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 73. GlaxoSmithKline Incretin-Based Drugs Product
Table 74. GlaxoSmithKline Recent Developments/Updates
Table 75. Johnson & Johnson Company Information
Table 76. Johnson & Johnson Description and Business Overview
Table 77. Johnson & Johnson Incretin-Based Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 78. Johnson & Johnson Incretin-Based Drugs Product
Table 79. Johnson & Johnson Recent Developments/Updates
Table 80. Merck & Co Company Information
Table 81. Merck & Co Description and Business Overview
Table 82. Merck & Co Incretin-Based Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 83. Merck & Co Incretin-Based Drugs Product
Table 84. Merck & Co Recent Developments/Updates
Table 85. AstraZeneca Company Information
Table 86. AstraZeneca Description and Business Overview
Table 87. AstraZeneca Incretin-Based Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 88. AstraZeneca Incretin-Based Drugs Product
Table 89. AstraZeneca Recent Developments/Updates
Table 90. Novartis Company Information
Table 91. Novartis Description and Business Overview
Table 92. Novartis Incretin-Based Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 93. Novartis Incretin-Based Drugs Product
Table 94. Novartis Recent Developments/Updates
Table 95. Eli Lilly and Company Company Information
Table 96. Eli Lilly and Company Description and Business Overview
Table 97. Eli Lilly and Company Incretin-Based Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 98. Eli Lilly and Company Incretin-Based Drugs Product
Table 99. Eli Lilly and Company Recent Developments/Updates
Table 100. Boehringer Ingelheim Company Information
Table 101. Boehringer Ingelheim Description and Business Overview
Table 102. Boehringer Ingelheim Incretin-Based Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 103. Boehringer Ingelheim Incretin-Based Drugs Product
Table 104. Boehringer Ingelheim Recent Developments/Updates
Table 105. Takeda Pharmaceutical Company Company Information
Table 106. Takeda Pharmaceutical Company Description and Business Overview
Table 107. Takeda Pharmaceutical Company Incretin-Based Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 108. Takeda Pharmaceutical Company Incretin-Based Drugs Product
Table 109. Takeda Pharmaceutical Company Recent Developments/Updates
Table 110. Sanofi Company Information
Table 111. Sanofi Description and Business Overview
Table 112. Sanofi Incretin-Based Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 113. Sanofi Incretin-Based Drugs Product
Table 114. Sanofi Recent Developments/Updates
Table 115. Key Raw Materials Lists
Table 116. Raw Materials Key Suppliers Lists
Table 117. Incretin-Based Drugs Distributors List
Table 118. Incretin-Based Drugs Customers List
Table 119. Incretin-Based Drugs Market Trends
Table 120. Incretin-Based Drugs Market Drivers
Table 121. Incretin-Based Drugs Market Challenges
Table 122. Incretin-Based Drugs Market Restraints
Table 123. Research Programs/Design for This Report
Table 124. Key Data Information from Secondary Sources
Table 125. Key Data Information from Primary Sources
Table 126. Authors List of This Report
List of Figures
Figure 1. Product Picture of Incretin-Based Drugs
Figure 2. Global Incretin-Based Drugs Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Incretin-Based Drugs Market Share by Type: 2024 & 2031
Figure 4. Glucagon-like peptide-1 receptor (GLP-1) agonists Product Picture
Figure 5. Dipeptidyl Peptidase-4 (DPP-4) inhibitors Product Picture
Figure 6. Global Incretin-Based Drugs Market Value by Application (2020-2031) & (US$ Million)
Figure 7. Global Incretin-Based Drugs Market Share by Application: 2024 & 2031
Figure 8. Oral Drugs
Figure 9. Injectable Drugs
Figure 10. Global Incretin-Based Drugs Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 11. Global Incretin-Based Drugs Market Size (2020-2031) & (US$ Million)
Figure 12. Global Incretin-Based Drugs Sales (2020-2031) & (K Units)
Figure 13. Global Incretin-Based Drugs Average Price (US$/Unit) & (2020-2031)
Figure 14. Incretin-Based Drugs Report Years Considered
Figure 15. Incretin-Based Drugs Sales Share by Manufacturers in 2024
Figure 16. Global Incretin-Based Drugs Revenue Share by Manufacturers in 2024
Figure 17. Global 5 and 10 Largest Incretin-Based Drugs Players: Market Share by Revenue in Incretin-Based Drugs in 2024
Figure 18. Incretin-Based Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 19. Global Incretin-Based Drugs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 20. North America Incretin-Based Drugs Sales Market Share by Country (2020-2031)
Figure 21. North America Incretin-Based Drugs Revenue Market Share by Country (2020-2031)
Figure 22. U.S. Incretin-Based Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 23. Canada Incretin-Based Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 24. Europe Incretin-Based Drugs Sales Market Share by Country (2020-2031)
Figure 25. Europe Incretin-Based Drugs Revenue Market Share by Country (2020-2031)
Figure 26. Germany Incretin-Based Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 27. France Incretin-Based Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 28. U.K. Incretin-Based Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 29. Italy Incretin-Based Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 30. Russia Incretin-Based Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 31. Asia Pacific Incretin-Based Drugs Sales Market Share by Region (2020-2031)
Figure 32. Asia Pacific Incretin-Based Drugs Revenue Market Share by Region (2020-2031)
Figure 33. China Incretin-Based Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 34. Japan Incretin-Based Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 35. South Korea Incretin-Based Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 36. India Incretin-Based Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 37. Australia Incretin-Based Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 38. Taiwan Incretin-Based Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. Indonesia Incretin-Based Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. Thailand Incretin-Based Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. Malaysia Incretin-Based Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 42. Philippines Incretin-Based Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 43. Latin America Incretin-Based Drugs Sales Market Share by Country (2020-2031)
Figure 44. Latin America Incretin-Based Drugs Revenue Market Share by Country (2020-2031)
Figure 45. Mexico Incretin-Based Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 46. Brazil Incretin-Based Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 47. Argentina Incretin-Based Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 48. Middle East and Africa Incretin-Based Drugs Sales Market Share by Country (2020-2031)
Figure 49. Middle East and Africa Incretin-Based Drugs Revenue Market Share by Country (2020-2031)
Figure 50. Turkey Incretin-Based Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 51. Saudi Arabia Incretin-Based Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 52. UAE Incretin-Based Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 53. Global Sales Market Share of Incretin-Based Drugs by Type (2020-2031)
Figure 54. Global Revenue Market Share of Incretin-Based Drugs by Type (2020-2031)
Figure 55. Global Incretin-Based Drugs Price (US$/Unit) by Type (2020-2031)
Figure 56. Global Sales Market Share of Incretin-Based Drugs by Application (2020-2031)
Figure 57. Global Revenue Market Share of Incretin-Based Drugs by Application (2020-2031)
Figure 58. Global Incretin-Based Drugs Price (US$/Unit) by Application (2020-2031)
Figure 59. Incretin-Based Drugs Value Chain
Figure 60. Channels of Distribution (Direct Vs Distribution)
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Outdoor Shed Market Research Report 2025
Sep 09, 25
Global Residential Outdoor Cabinet Market Research Report 2025
Sep 09, 25
Global Outdoor Storage Cabinet Market Research Report 2025
Sep 09, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232